Florida Man Pleads Guilty in $42 Million Medicare Fraud Scheme

A Florida man pleaded guilty in a case federal prosecutors described as a roughly $42 million Medicare fraud scheme involving medical braces and cancer genetic-testing referrals. Authorities also said he fraudulently obtained a pandemic-era business relief loan.

Chad Monroe, 48, of Tarpon Springs, Florida, pleaded guilty on November 13 to conspiracy to commit health care fraud and wire fraud. The Justice Department said three medical-equipment companies he controlled submitted more than $26 million in false claims, while laboratories paid him more than $15 million in illegal kickbacks connected to genetic-testing orders.

Those figures describe different parts of the scheme. The amount billed by equipment suppliers is not necessarily the amount insurers paid, and kickbacks received for test referrals are not the same thing as reimbursement claims. The Justice Department’s plea announcement does not identify $42 million as the amount Medicare disbursed or as a court-ordered loss figure.

The guilty plea follows an investigation into the suppliers, their enrollment information and the doctors’ orders used to obtain payments. In its announcement of the plea, the Justice Department said the equipment and tests involved were unwanted or medically unnecessary for the beneficiaries in whose names they were ordered.

How the medical-equipment claims were generated

Monroe and his co-conspirators operated Maksix Medical Products Inc., Orthotech Atlanta LLC and 1st Choice Medical Supply LLC, according to federal prosecutors. The businesses billed Medicare, private Medicare Advantage plans and TRICARE, the health program serving eligible military personnel and their families. The equipment included knee, wrist, ankle and back braces.

A central part of the operation was obtaining signed medical orders. Prosecutors said Monroe paid illegal kickbacks to purported telemedicine companies to secure orders that could be submitted with claims for braces. The orders gave suppliers documentation to support billing even though the underlying equipment was not wanted or needed by the people listed as patients.

Ownership records were another part of the case. Monroe directed associates to provide false information on Medicare enrollment documents to conceal his financial interest in and management of the suppliers, the Justice Department said. These false records obscured who actually controlled the businesses submitting claims.

The original indictment, filed in June 2025 in the Middle District of Florida, placed the companies in different states. It described Maksix as initially incorporated in Arizona and later operating in North Carolina, Orthotech as a Georgia company and 1st Choice as based in Florida’s Pinellas County. Prosecutors alleged that the brace-billing activity extended across several years, rather than being confined to a short period or a single location.

The charging document also distinguished billed amounts from money paid. It alleged that Medicare paid roughly $9.1 million on false brace claims attributed to those three suppliers, with additional payments by Medicare Advantage plans and TRICARE. That was the prosecution’s account when charges were filed, not an updated restitution determination in the guilty-plea announcement. The distinction is important when assessing the financial impact of the case.

More than $15 million tied to genetic-testing orders

The equipment claims were only one part of the case. Through Health and Life Networking LLC, Monroe marketed and sold doctors’ orders for cancer genetic testing to laboratories participating in the scheme. The Justice Department said those laboratories paid him more than $15 million in illegal kickbacks.

This side of the operation depended on generating orders that laboratories could use to seek reimbursement for testing. The government said Monroe paid purported telemedicine businesses to obtain the orders, then sold genetic-testing referrals to laboratories. That created a financial incentive to produce orders whether or not a test met a patient’s medical needs.

The 2025 indictment alleged that the referral payments were sometimes disguised through sham agreements and invoices described as marketing fees. According to those allegations, payments were actually tied to individual doctors’ orders, braces or a share of genetic-testing reimbursements. Those details come from the charging document; the Justice Department’s later plea announcement did not separately establish every allegation in the indictment as a finding by the court.

Cancer genetic testing can be an appropriate part of treatment, but coverage depends on the clinical circumstances. A Medicare coverage policy on oncology genetic tests states that tests must be medically necessary and ordered in connection with a patient’s care, rather than treated as routine screening without a relevant medical indication. That helps explain why a signed order alone does not make a claim appropriate for payment.

Federal anti-kickback rules address a related problem: paying or receiving something of value in exchange for referrals for services covered by government health programs. In this case, the alleged misconduct was not telemedicine or genetic testing as such. Prosecutors described a system for buying medical orders and turning them into insurance claims or referral payments without the required medical justification.

Pandemic loan fraud, seized assets and sentencing

The guilty plea also covered misconduct involving federal small-business assistance. Monroe directed another person to seek a Paycheck Protection Program loan of more than $30,000 for 1st Choice Medical Supply, according to the Justice Department. The application misstated ownership information, including who controlled the company, to qualify for the loan.

That loan was separate from the medical-equipment and genetic-testing activity. The Paycheck Protection Program was intended to support eligible businesses during the pandemic, and applicants were required to provide accurate information about their companies. The false ownership statements therefore had consequences beyond whether particular medical claims were payable.

Prosecutors also described how Monroe spent money obtained through the fraud. They said he purchased a 47-foot yacht called “The Rogue Shark,” valued at more than $600,000, along with a Cadillac Escalade and other luxury vehicles. Federal authorities seized the yacht and more than $1 million in connection with the charges. The seizures do not, on their own, establish the total loss or the final amount that a court may order him to repay.

The case was initially included in the Justice Department’s national health care fraud enforcement announcement in June 2025. Investigators included the Department of Health and Human Services Office of Inspector General, the FBI, the Defense Criminal Investigative Service and IRS Criminal Investigation, reflecting the involvement of health benefits, military-related coverage and financial records.

Monroe faces a statutory maximum of 10 years in prison on the health care fraud conspiracy count and 30 years on the wire fraud count. Those are maximum penalties for the individual offenses, not a sentence already imposed. A federal judge will determine the punishment after reviewing the sentencing guidelines and other relevant factors. No sentencing date had been set when the Justice Department announced the plea.